Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1985-08-19
1986-09-23
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 11, 536 187, 536 53, 536 55, A61K 3170, C07H 308
Patent
active
046135898
ABSTRACT:
Derivatives of 3-deoxy-D-manno-2-octulosonic acid (KDO) are potent inhibitors of bacterial enzymes and a novel class of antibacterial agents.
REFERENCES:
patent: 3719659 (1973-03-01), Magerlein
patent: 4454123 (1984-06-01), Noyori et al.
Charon et al., "J.C.S." Perkin I, pp. 1971-1977, 1980.
Collins et al., "J.C.S. Chem. Comm.", pp. 1139-1140, 1981.
Strain et al., "J. Bio. Chem.", vol. 258, No. 22, pp. 13466-13477, 1983.
Strain et al., "J. Bio. Chem.", vol. 258, No. 5, pp. 2906-2910, 1983.
Bigham et al., "J. Med. Chem.", vol. 27, pp. 717-726, 1984.
Molin et al., "Tetrahedron Letters", vol. 26, No. 5, pp. 677-680, 1985.
Lartey Paul A.
Riley David A.
Rosenbrook William
Abbott Laboratories
Brown Johnnie R.
Katz Martin L.
Weinstock Steven F.
LandOfFree
D-manno-2-octulosonic acid derivatives, pharmaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with D-manno-2-octulosonic acid derivatives, pharmaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and D-manno-2-octulosonic acid derivatives, pharmaceutical compositi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-766394